HSPD1 Antikörper (AA 250-300)
-
- Target Alle HSPD1 Antikörper anzeigen
- HSPD1 (Heat Shock 60kDa Protein 1 (Chaperonin) (HSPD1))
-
Bindungsspezifität
- AA 250-300
-
Reaktivität
- Human, Maus, Ratte, Hund, Rind (Kuh), Kaninchen, Xenopus laevis, Pferd
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HSPD1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Proximity Ligation Assay (PLA)
- Spezifität
- Region between residue 250 and 300 of human Heat Shock Protein 60 using the numbering given in entry NP_002147.2 (GeneID 3329).
- Aufreinigung
- Immunoaffinity purified
- Isotyp
- IgG
- Top Product
- Discover our top product HSPD1 Primärantikörper
-
-
- Applikationshinweise
-
Approved: IF (1:100 - 1:500), IHC, IHC-P (1:200 - 1:1000), IP (2 - 5 μg/mg lysate), PLA (1:200 - 1:4000), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Breast Carcinoma, Colon Carcinoma, Ovarian Carcinoma, Prostate Carcinoma. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store at 2-8°C for up to 1 year.
- Haltbarkeit
- 12 months
-
- Target
- HSPD1 (Heat Shock 60kDa Protein 1 (Chaperonin) (HSPD1))
- Andere Bezeichnung
- HSPD1 / HSP60 (HSPD1 Produkte)
- Hintergrund
-
Name/Gene ID: HSPD1
Synonyms: HSPD1, 60 kDa chaperonin, CPN60, Heat shock protein 65, Heat shock protein 60, HSP-60, HSP60, HuCHA60, HLD4, HSP65, p60 lymphocyte protein, SPG13, Chaperonin 60, GROEL - Gen-ID
- 3329
- Pathways
- Activation of Innate immune Response, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Positive Regulation of Endopeptidase Activity
-